Thrombosis
News
Drug granted fast track designation for PNH
The US Food and Drug Administration (FDA) has granted fast track designation for the complement C3 inhibitor APL-2. The designation applies to...
News
Health Canada approves therapy for hemophilia A
Health Canada has approved the use of lonoctocog alfa (Afstyla), a recombinant factor VIII (FVIII) single-chain therapy, in hemophilia A patients...
Conference Coverage
Gene transfer for hemophilia B shows progress
SAN DIEGO—Researchers say they have optimized the SPK-9001 adeno-associated viral (AAV) vector so that a “simple infusion” has significantly...
Conference Coverage
First-in-kind study parsed risks of central lines in children
SAN DIEGO - Rising rates of pediatric venous thromboembolism in the United States underscore the need to carefully weigh the risks and benefits of...
From the Journals
Age correlated with occult cancer in VTE patients
The percentage of VTE patients who had occult cancer increased with advancing age, from 2%-3% in the youngest age group to 8%-12% in the oldest...
News
Testosterone therapy may increase VTE risk temporarily
(Depo-Testosterone) Starting testosterone treatment is associated with an increased risk of venous thromboembolism (VTE) that peaks within 6...
News
Responsive patch prevents thrombosis in mice
Photo by Aaron Logan Researchers have created a patch designed to monitor a patient’s blood and release heparin as needed to prevent thrombosis...
News
System could enable oral treatment of hemophilia, team says
Photo courtesy of the CDC Researchers say they have developed biodegradable hydrophilic carriers that could provide oral delivery of factor IX (...
Conference Coverage
VIDEO: HeartMate 3 LVAD solves pump thrombosis
NEW ORLEANS – HeartMate 3, the latest left ventricular assist device in the HeartMate line, appears to have solved the problem of pump thrombosis...
News
AEs from anticoagulants common cause of ED visits
caring for a patient Photo by Tom Watanabe A new study has revealed which drugs most commonly caused adverse events (AEs) leading to emergency...
News
EC grants drug orphan designation for PNH
The European Commission (EC) has granted orphan drug designation to RA101495 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)....